Dr. Paul Amundson, CMO, DAKOTACARE. “To do what eviti is doing, we would have to have a fulltime nurse and probably a fulltime oncologist here on staff. What we wanted was a better way to do oversight of oncology, specifically for high-dollar oncology agents’ radiation therapy treatment plans. We wanted a process that could give us all that oversight in an easy-to-use format.”
Rebecca Tidemann, Case Manager, DAKOTACARE. “With eviti, you know it’s evidence-based, you know it’s been reviewed, and you feel very comfortable knowing that that treatment plan is appropriate. Before we really started working with eviti, providers would call in and ask about clinical trial A or clinical trial B or treatment plan A or treatment plan B and say is this evidence based? Is this appropriate?”
Dr. Paul Amundson, CMO, DAKOTACARE. “It helps us because it assists our members and our clients, so our members know that they are getting top-of-the-line, state-of-the-art, nationally recognized treatment plans and for our clients it gives them an increased level of assurance that what they’re paying for, for their employee or for their employee’s dependents is also top-of-the-line, state-of-the-art, nationally recognized treatment plans.”
Rebecca Tidemann, Case Manager, DAKOTACARE. “Because it is so comprehensive, because there is such a wealth of information supporting that, and the leading experts in this field supporting that. You feel very comfortable knowing that once you have that eviti code, and you have that eviti submission, you know that patient is going to get the best care.”
Dr. Paul Amundson, CMO, DAKOTACARE. “Probably the biggest thing that eviti brings to the table is the improved efficiency at the provider’s office. The provider’s office can get results back very quickly and we felt that eviti really was the number one vendor that we could find for that type of service.”
